✦ LIBER ✦

Pharmacokinetic, pharmacodynamic, and tolerability profiles of the dipeptidyl peptidase-4 inhibitor alogliptin: A randomized, double-blind, placebo-controlled, multiple-dose study in adult patients with type 2 diabetes

✍ Scribed by Paul Covington; Ronald Christopher; Michael Davenport; Penny Fleck; Qais A. Mekki; Elisabeth R. Wann; Aziz Karim

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetics, pharmacodynamics and t

✍ T. Heise; E. U. Graefe-Mody; S. Hüttner; A. Ring; D. Trommeshauser; K. A. Dugi 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 266 KB

Pharmacokinetic and Pharmacodynamic Asse

✍ A. Marie O'Farrell; Andre van Vliet; Khalid Abou Farha; Julie M. Cherrington; Da 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 898 KB

Efficacy and safety of adding the dipept

✍ M. A. Nauck; G. C. Ellis; P. R. Fleck; C. A. Wilson; Q. Mekki; for the Aloglipti 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 218 KB

Pharmacokinetics, pharmacodynamics, and

✍ Kyoung Soo Lim; Jung-Ryul Kim; Yun-Jung Choi; Kwang-Hee Shin; Kyu-Pyo Kim; Jang- 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 169 KB

Efficacy and safety of the dipeptidyl pe

✍ R. E. Pratley; M. S. Kipnes; P. R. Fleck; C. Wilson; Q. Mekki; Alogliptin Study 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 157 KB

Pharmacokinetics, Pharmacodynamics, and

✍ Sanwald-Ducray, P; Liogier D'ardhuy, X; Jamois, C; Banken, L 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 184 KB